RxDoctor Payments Data

Raj Gala, MD

Orthopaedic Surgery of the Spine · New Haven, CTNPI 1457797276

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (55.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Globus Medical at 28.8% of the total. Reporting peaked in 2021 at $7,795 and has fallen 55.5% since, to $3,470 in 2025.

$20,544in general payments, 2019–2025

Across 123 payments — averaging $167.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$6K
  • Alphatec Spine, Inc$4K
  • Spine Wave, Inc.$4K
  • Medical Device Business Services, Inc.$2K
  • Boston Scientific$2K
  • Si-bone, Inc.$563
  • plus $2K from 14 others

What the payments were for

  • Consulting fees$3,80018%
  • Travel & lodging$11,40556%
  • Food & beverage$5,33926%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,544 in reported general payments places this provider in the 55th percentile of 25 orthopaedic surgery of the spine providers in Connecticut.

See all orthopaedic surgery of the spine providers in Connecticut

Medicare billing

Part B allowed, 2024
$68,514
Medicare patients
129
Services billed
281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin16$122
Chlorhexidine Gluconate16$79

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →